ageas SA/NV (AGS)
Jul 1, 2025 - AGS was delisted (reason: acquired by Brightstar)
12.49
+0.01 (0.08%)
Inactive · Last trade price on Jun 30, 2025

Intra-Cellular Therapies Revenue

In the year 2024, PlayAGS had annual revenue of 8.51B EUR with 13.04% growth. PlayAGS had revenue of 4.20B in the half year ending December 31, 2024, a decrease of -21.03%.

Revenue (ttm)
8.51B EUR
Revenue Growth
+13.04%
P/S Ratio
1.49
Revenue / Employee
506,698 EUR
Employees
16,797
Market Cap
13.11B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.51B982.00M13.04%
Dec 31, 20237.53B538.00M7.70%
Dec 31, 20226.99B-6.47B-48.06%
Dec 31, 202113.46B1.51B12.65%
Dec 31, 202011.95B-2.81B-19.06%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.